Sunday, August 14, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models

by Medical Finance
in Coronavirus
Study: Ocular tropism of SARS-CoV-2 with retinal inflammation through neuronal invasion in animal models. Image Credit: Kateryna Kon/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated ocular tropism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through neuronal invasion in transgenic mice with human angiotensin-converting enzyme 2 (hACE2) expression.

Study: Ocular tropism of SARS-CoV-2 with retinal inflammation through neuronal invasion in animal models. Image Credit: Kateryna Kon/Shutterstock
Study: Ocular tropism of SARS-CoV-2 with retinal inflammation through neuronal invasion in animal models. Image Credit: Kateryna Kon/Shutterstock

Background

Since ocular mucosa serves as an additional mucosal surface for infectious aerosols, the eyes might become a potential transmission route of SARS-CoV-2, causing ocular diseases in humans.

In vitro studies have evidenced that SARS-CoV-2 infects human embryonic stem cell-derived ocular epithelial cells and conjunctival epithelial cells. In animals, e.g., rhesus macaques, studies have demonstrated SARS-CoV-2 entry via the conjunctiva. Likewise, post-mortem studies have detected SARS-CoV-2 ribonucleic acid (RNA) in the conjunctival swabs of coronavirus disease 2019 (COVID-19) patients, with or without ocular manifestations.

Although studies have reported ocular abnormalities in COVID-19 patients, the pathology and ocular tropism of SARS-CoV-2 are still unknown. Elucidation of whether the eyes are a primary or secondary site for viral entry is crucial for developing therapeutic strategies against ocular and neuronal infection-mediated disorders in COVID-19 patients.

About the study

In the present study, researchers demonstrated SARS-CoV-2 ocular tropism via neuronal invasion of trigeminal (TN) and optic nerves (ON) in the K18-hACE2 mice. They challenged K18-hACE2 mice intranasally (IN) with approximately 104 plaque-forming units (PFU) of SARS-CoV-2 and the mock group with the same volume of phosphate buffer saline (PBS).

To validate the hypothesis that SARS-CoV-2 transmits to the brain and eyes via TN and ON, the team infected mice with 104 PFU of SARS-CoV-2 using four injection routes, viz., intratracheal (IT), intracerebral (IC), eye-drop (ED), and intravenous (IV). They assessed weight loss in mice and viral loads in the lungs, brain, eyes, TN, and ON of mice between three and six days post-infection (dpi).

Furthermore, they showed the ocular tropic and neuroinvasive characteristics of SARS-CoV-2 in wild-type Syrian hamsters.

The researchers examined the neurotropic and ocular distribution of SARS-CoV-2 in vivo using a fluorescence-imaging system. At six dpi, the team assayed the virus quantity in the lungs and eyes using a plaque assay. Similarly, they used nucleocapsid (N) gene-targeting quantitative reverse transcription-polymerase chain reaction (RT-qPCR) to assess SARS-CoV-2 RNA copies in the lacrimal gland.

Furthermore, the researchers examined inflammatory and histopathological changes due to SARS-CoV-2 infection using hematoxylin and eosin (H&E)-stained eye sections from mock- and SARS-CoV-2-infected mice. They also measured retinal thickness, from the ganglion to the nuclear cell layers, post-infection to estimate retinal inflammation.

Lastly, the researchers evaluated the functional consequences of retinal inflammation on visual behavior using the visual cliff test. They tested each mouse only once to avoid a memory effect and randomized the test order.

Study findings

The authors observed around 20% weight loss at seven dpi and mortality at eight dpi. On six dpi, they also observed tearing and eye discharge in one-fourth of the infected mice. The infectious viral titer of the eyes was as high as that of the lung (~106 PFU/g).

Surprisingly, the viral load of the lacrimal gland was much diminished than that of the eyes but similar to that of the spleen (~104 viral RNA copies/mg of total RNA), barely susceptible to SARS-CoV-2 infection. These results demonstrated the presence of infectious viruses in the eyes, suggesting that the eyes are a target of SARS-CoV-2 infection.

SARS-CoV-2 infection increased the retinal thickness by 1.62-fold due to the accumulation of infiltrating inflammatory cells in the ganglion and nuclear cell layers. Compared to the mock group, there were apparent lesions in retinal tissues in the SARS-CoV-2-infected mice. Accordingly, the mean retinal thickness of the infected mice was 75.14 µm, much higher than that of mock mice (46.27 µm).

The multiplex immuno-analysis of the eyes showed augmentation in pro-inflammatory chemokines and cytokines in response to SARS-CoV-2 infection on six dpi in mice. The authors observed substantially elevated levels of the following cytokines: granulocyte colony-stimulating factor (G-CSF), interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein 2 (MIP-2), and interleukin 12 (IL-12).

These chemokines and cytokines were augmented, particularly in the brain, where the viral load was higher than in the eyes, indicating that IN-administered SARS-CoV-2 promoted retinal inflammation and cytokine production in the eyes of K18-hACE2 mice.

The mice of mock and SARS-CoV-2-infected groups dismounted the visual cliff test platform on an average within 4.28 and 3.56 seconds, respectively. Specifically, SARS-CoV-2-infected mice with ocular symptoms showed a prolonged latency for the dismounting up to 42.92 seconds. Notably, the retinal inflammation due to SARS-CoV-2 infection did not worsen retinal degeneration or visual loss.

The IN injection resulted in ocular tropism with increased viral RNA levels in the eyes between three and six dpi. However, the authors observed mortality only in mice injected via the IC route after two dpi. The viral RNA titers in the TN and ON were almost equal in the brain and eyes, indicating viral transmission to the eyes and brain via the neuronal invasion of these nerves.

Conclusions

In the present study, an infectious SARS-CoV-2-mCherry clone (with a fluorescent reporter gene) generated by a reverse genetics system helped the researchers trace viral infection and tropism in vivo.

Robust fluorescence signals in the TN and ON of infected mice validated the neuronal invasion of SARS-CoV-2. It demonstrated that SARS-CoV-2 used TNs, along with ONs to reach the brain and the eyes.

Future studies should investigate the clinical relevance of SARS-CoV-2-induced ocular inflammation and manifestations because not only respiratory organs but other organs, including eyes and TNs, are susceptible to SARS-CoV-2 infection.

*Important notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins. Image Credit: pinkeyes/Shutterstock

Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

by Medical Finance
August 14, 2022
0

In a recent study published in the International Journal of Molecular Sciences, researchers identified and validated multiple linear B-cell epitopes...

Study: Adolescents and Resilience: Factors Contributing to Health-Related Quality of Life during the COVID-19 Pandemic. Image Credit: BearFotos/Shutterstock

Study considers factors contributing to health-related quality of life in adolescents during the COVID-19 pandemic

by Medical Finance
August 14, 2022
0

Coronavirus 2019 (COVID-19) outbreaks happen quickly, leading to an increase in worldwide morbidity and mortality. As a result, the global population is...

Study: Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19. Image Credit: Naeblys/Shutterstock

3C-like protease inhibitor clinical candidate, S-217622, as a treatment for SARS-CoV-2

by Medical Finance
August 14, 2022
0

In a recent study posted to the bioRxiv* pre-print server, a team of researchers discovered S-217622, a non-covalent severe acute...

Study: Biodistribution and Environmental Safety of a Live-attenuated YF17D-vectored SARS-CoV-2 Vaccine Candidate. Image Credit: PanyaStudio/Shutterstock

Yellow fever vaccine-vectored YF-S0 as a potent COVID-19 vaccine candidate

by Medical Finance
August 14, 2022
0

In a recent study posted to the bioRxiv* pre-print server, a team of researchers developed YF-S0, an exceptionally potent coronavirus...

Study: Interleukin-1 blocking agents for treating COVID-19. Image Credit: Juan Gaertner / Shutterstock.com

Study finds limited evidence for IL-1 blockers in treating COVID-19

by Medical Finance
August 14, 2022
0

In a recent Cochrane Database of Systematic Reviews study, researchers assess the effectiveness and safety outcomes of interleukin-1 (IL-1) blocking...

New evidence supports the link between growth-induced respiratory stress and fish reproduction

COVID-19 infections tend to be milder in fully vaccinated patients

by Medical Finance
August 14, 2022
0

The clinical and imaging characteristics of COVID-19 breakthrough infections in fully vaccinated patients tend to be milder than those of...

Next Post
Study: In silico analysis of predicted differential MHC binding and CD8+ T-cell immune escape of SARS-CoV-2 B.1.1.529 variant mutant epitopes. Image Credit: Fit Ztudio/Shutterstock

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Study: Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia. Image Credit: Nor Gal/Shutterstock

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not antigen-experienced vaccinees. Image Credit: BaLL LunLa/Shutterstock
    mRNA COVID-19 vaccine shown to induce afucosylated antibodies in individuals without prior SARS-CoV-2 exposure
  • pill antibiotics 620x480
    Theoretical biologists capture the mechanisms underlying evolvability
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply